NIH Closes Doors for Secret Grant Review Sessions
Published Date: 5/12/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in late May and June 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research institutions waiting on grants should note these dates as they impact funding decisions.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Grant review dates affect applicants
The Center for Scientific Review will hold closed virtual grant-review meetings on May 29, 2026; June 11, 2026; June 15-16, 2026; and June 16, 2026. If you are a scientist or research institution waiting on NIH grant decisions, these meetings set the dates when your applications will be reviewed and therefore affect the timing of funding decisions.
Confidentiality protections for applicants
The meetings are closed under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property like patentable material, and personal information about individuals linked to grant applications. This protects applicants' proprietary information and personal privacy during the review process.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
Previous / Next Documents
Previous: 2026-09322 — Certain Crystalline Silicon Photovoltaic Products From Taiwan: Preliminary Results of Antidumping Duty Administrative Review; 2024-2025
The U.S. Department of Commerce checked if solar products from Taiwan were being sold too cheaply in the U.S. from Feb 2024 to Jan 2025 and found they were not. This means no extra taxes (antidumping duties) will be added for now. Companies involved, especially EEPV Corp., can share their thoughts before the final decision.
Next: 2026-09324 — National Institute of Allergy and Infectious Diseases; Notice of Meetings
The National Institute of Allergy and Infectious Diseases is holding virtual meetings on June 22, 2026, to review grant applications and share important updates. These meetings affect researchers and organizations seeking funding, with some sessions open to the public online and others closed to protect privacy. No new funding amounts are announced, but the grant review could impact future research support.